Menu
GWAS Study

Genome-wide Gene-by-Sex Interaction Studies Identify Novel Nonsyndromic Orofacial Clefts Risk Locus.

Awotoye W, Comnick C, Pendleton C et al.

34689653 PubMed ID
GWAS Study Type
3178 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AW
Awotoye W
CC
Comnick C
PC
Pendleton C
ZE
Zeng E
AA
Alade A
MP
Mossey PA
GL
Gowans LJJ
EM
Eshete MA
AW
Adeyemo WL
NT
Naicker T
AC
Adeleke C
BT
Busch T
LM
Li M
PA
Petrin A
OJ
Olotu J
HM
Hassan M
PJ
Pape J
MS
Miller SE
DP
Donkor P
AD
Anand D
LS
Lachke SA
MM
Marazita ML
AA
Adeyemo AA
MJ
Murray JC
AD
Albokhari D
SN
Sobreira N
BA
Butali A
Chapter II

Abstract

Summary of the research findings

Risk loci identified through genome-wide association studies have explained about 25% of the phenotypic variations in nonsyndromic orofacial clefts (nsOFCs) on the liability scale. Despite the notable sex differences in the incidences of the different cleft types, investigation of loci for sex-specific effects has been understudied. To explore the sex-specific effects in genetic etiology of nsOFCs, we conducted a genome-wide gene × sex (GxSex) interaction study in a sub-Saharan African orofacial cleft cohort. The sample included 1,019 nonsyndromic orofacial cleft cases (814 cleft lip with or without cleft palate and 205 cleft palate only) and 2,159 controls recruited from 3 sites (Ethiopia, Ghana, and Nigeria). An additive logistic model was used to examine the joint effects of the genotype and GxSex interaction. Furthermore, we examined loci with suggestive significance (P < 1E-5) in the additive model for the effect of the GxSex interaction only. We identified a novel risk locus on chromosome 8p22 with genome-wide significant joint and GxSex interaction effects (rs2720555, p2df = 1.16E-08, pGxSex = 1.49E-09, odds ratio [OR] = 0.44, 95% CI = 0.34 to 0.57). For males, the risk of cleft lip with or without cleft palate at this locus decreases with additional copies of the minor allele (p < 0.0001, OR = 0.60, 95% CI = 0.48 to 0.74), but the effect is reversed for females (p = 0.0004, OR = 1.36, 95% CI = 1.15 to 1.60). We replicated the female-specific effect of this locus in an independent cohort (p = 0.037, OR = 1.30, 95% CI = 1.02 to 1.65), but no significant effect was found for the males (p = 0.29, OR = 0.86, 95% CI = 0.65 to 1.14). This locus is in topologically associating domain with craniofacially expressed and enriched genes during embryonic development. Rare coding mutations of some of these genes were identified in nsOFC cohorts through whole exome sequencing analysis. Our study is additional proof that genome-wide GxSex interaction analysis provides an opportunity for novel findings of loci and genes that contribute to the risk of nsOFCs.

1,019 Sub-Saharan African ancestry cases, 2,159 Sub-Saharan African ancestry controls

Chapter III

Study Statistics

Key metrics and study information

3178
Total Participants
GWAS
Study Type
No
Replicated
Sub-Saharan African
Ancestry
Ghana, Nigeria, Ethiopia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.